SFSIG
REGN icon

San Francisco Sentry Investment Group’s Regeneron Pharmaceuticals REGN Stock Holding History

San Francisco Sentry Investment Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$3K Hold
5
– – ﹤0.01% 610
2021
Q1 		$2K Hold
5
– – ﹤0.01% 686
2020
Q4 		$2K Sell
5
-53
-91% -$28.6K ﹤0.01% 652
2020
Q3 		$32K Buy
58
+2
+4% +$1.21K 0.02% 380
2020
Q2 		$35K Buy
56
+46
+460% +$26.1K 0.02% 371
2020
Q1 		$5K Hold
10
– – ﹤0.01% 560
2019
Q4 		$4K Hold
10
– – ﹤0.01% 667
2019
Q3 		$3K Hold
10
– – ﹤0.01% 704
2019
Q2 		$3K Sell
10
-7
-41% -$2.33K ﹤0.01% 704
2019
Q1 		$7K Hold
17
– – ﹤0.01% 602
2018
Q4 		$6K Buy
17
+4
+31% +$1.46K ﹤0.01% 619
2018
Q3 		$5K Sell
13
-622
-98% -$237K ﹤0.01% 666
2018
Q2 		$219K Sell
635
-454
-42% -$142K 0.09% 186
2018
Q1 		$375K Buy
1,089
+11
+1% +$3.83K 0.11% 180
2017
Q4 		$405K Sell
1,078
-251
-19% -$102K 0.12% 175
2017
Q3 		$594K Buy
1,329
+69
+5% +$32.8K 0.2% 118
2017
Q2 		$618K Hold
1,260
– – 0.22% 103
2017
Q1 		$488K Buy
1,260
+380
+43% +$141K 0.27% 92
2016
Q4 		$323K Buy
880
+300
+52% +$114K 0.19% 124
2016
Q3 		$233K Buy
+580
New +$233K 0.14% 149
2014
Q4 		– Sell
-265
Closed -$96K – 372
2014
Q3 		$96K Sell
265
-29
-10% -$9.72K 0.05% 226
2014
Q2 		$83K Hold
294
– – 0.04% 258
2014
Q1 		$88K Buy
294
+171
+139% +$52.7K 0.03% 287
2013
Q4 		$34K Sell
123
-1
-0.8% -$288 0.01% 377
2013
Q3 		$39K Hold
124
– – 0.01% 339
2013
Q2 		$28K Buy
+124
New +$28.9K 0.01% 378

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

San Francisco Sentry Investment Group's REGN Position: Q2 2021 in Review

San Francisco Sentry Investment Group held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2021 at 5 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #610.

San Francisco Sentry Investment Group first reported a position in REGN in Q2 2013 and has held it in 26 quarters since. The position peaked at $618K in Q2 2017. 971 funds tracked by Wall St. Rank hold REGN as of Q2 2021.

  • San Francisco Sentry Investment Group held 5 shares of Regeneron Pharmaceuticals worth $3K as of Q2 2021.
  • San Francisco Sentry Investment Group left its Regeneron Pharmaceuticals share count unchanged in Q2 2021.
  • Regeneron Pharmaceuticals made up ﹤0.01% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #610 holding.
  • San Francisco Sentry Investment Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 26 quarters since.
  • San Francisco Sentry Investment Group's Regeneron Pharmaceuticals position peaked at $618K in Q2 2017.
  • 971 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.